Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00510523 · ClinicalTrials.gov registry record · NA

Whole Body Vibration Therapy in Participants With MS Related Balance Deficits

A NA study of Multiple Sclerosis, sponsored by Logan College of Chiropractic.

Completed
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT00510523: Completed NA study of Multiple Sclerosis, sponsored by Logan College of Chiropractic.

NCT00510523 is a NA study of Multiple Sclerosis that has completed, run by Logan College of Chiropractic. The registered enrollment target is 80 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00510523, a NA study of Multiple Sclerosis, has completed, sponsored by Logan College of Chiropractic.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this investigation is to determine the effect of Whole Body Vibration Therapy (WBV) on balance in participants with multiple sclerosis (MS) related balance deficits as measured by the NeuroCom Balance Master, the Sapphire IIME EMG Device and the Kurtzke Expanded Disability Status Scale (EDSS) and the Berg Balance Score.

Conditions Studied

Interventions

  • DEVICE Whole Body Vibration machine

Study Locations (2)

Missouri

  • Logan University, College of Chiropractic - Chesterfield
  • Logan University, College of Chirpractic - Chesterfield

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2006-10
Est. Completion 2007-11
Phase NA
Logan College of Chiropractic

27 total trials

What the finished NCT00510523 record still lists

NCT00510523 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Whole Body Vibration machine is the first listed.

NCT00510523 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT00510523 about?

NCT00510523 is a clinical study titled "Whole Body Vibration Therapy in Participants With MS Related Balance Deficits". The purpose of this investigation is to determine the effect of Whole Body Vibration Therapy (WBV) on balance in participants with multiple sclerosis (MS) related balance deficits as measured by the NeuroCom Balance Master, the Sapphire IIME EMG Device and the Kurtzke Expanded Disability Status Scal...

What is the current status of trial NCT00510523?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2006-10. Estimated completion is 2007-11.

What conditions does trial NCT00510523 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT00510523?

The interventions under investigation include: Whole Body Vibration machine (DEVICE).

Who is sponsoring clinical trial NCT00510523?

This trial is sponsored by Logan College of Chiropractic, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00510523 being conducted?

This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00510523's enrollment target sits among peer trials

80 141st of 315 higher than 173 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00510523, the US trial registry maintained by the National Library of Medicine. NCT00510523 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.